Registry-listed formulations

Ecnoglutide · chembl:CHEMBL5095115

Each study is counted once in the molecule profile. Registry products remain separate. Naming an ingredient does not establish that products are interchangeable or what participants received.

9 source entries across 9 studies. This list may not include all unresolved or historical entries.

  • XW003 injectionRegistry intervention

    Linked study entry; product equivalence not established

    View study and source
  • XW003 injectionRegistry intervention

    Linked study entry; product equivalence not established

    View study and source
  • ecnoglutide tabletsRegistry intervention

    Linked study entry; product equivalence not established

    View study and source
  • VRB-101Registry intervention

    Linked study entry; product equivalence not established

    View study and source
  • XW003 injectionRegistry intervention

    Linked study entry; product equivalence not established

    View study and source
  • VRB-101Registry intervention

    Linked study entry; product equivalence not established

    View study and source
  • VRB-101Registry intervention

    Linked study entry; product equivalence not established

    View study and source
  • Ecnoglutide InjectionRegistry intervention

    Linked study entry; product equivalence not established

    View study and source
  • Ecnoglutide InjectionRegistry intervention

    Linked study entry; product equivalence not established

    View study and source

Success Metrics

Clinical Success Rate
100.0%

Based on 3 completed trials

Completion Rate
75%(3/4)
Active Trials
5(50%)
Results Posted
0%(0 trials)
Terminated
1(10%)

Phase Distribution

Phase 1
2
20%
Phase 1/2
1
10%
Phase 2
3
30%
Phase 3
4
40%

Phase Distribution

2

Early Stage

4

Mid Stage

4

Late Stage

Phase Distribution10 total trials
Phase 1Safety & dosage
2(20.0%)
Phase 1/2Combined phases
1(10.0%)
Phase 2Efficacy & side effects
3(30.0%)
Phase 3Large-scale testing
4(40.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

75.0%

3 of 4 finished

Non-Completion Rate

25.0%

1 ended early

Currently Active

5

trials recruiting

Total Trials

10

all time

Status Distribution
Active(6)
Completed(3)
Terminated(1)

Detailed Status

Recruiting4
Completed3
Active, not recruiting1
Terminated1
Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials
10
Active
5
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Phase 12 (20.0%)
Phase 1/21 (10.0%)
Phase 23 (30.0%)
Phase 34 (40.0%)

Trials by Status

active_not_recruiting110%
terminated110%
not_yet_recruiting110%
recruiting440%
completed330%

Recent Activity

5 active trials
Showing 5 of 10
terminatedphase_2

A Study of Weekly Oral Dose of Ecnoglutide (VRB-101) for Weight Maintenance in Participants Who Have Obesity or Overweight With Weight-Related Comorbidities

NCT07553299
recruitingphase_1

A Trial of Oral VRB-103 Alone or in Combination With Oral Ecnoglutide (VRB-101) in Participants With Obesity or Overweight

NCT07628127
not_yet_recruitingphase_3

A Study of Ecnoglutide Injection in Overweight or Obese Chinese Adolescents

NCT07836270
recruitingphase_1_2

A Phase Ib/IIa Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Oral Ecnoglutide Tablets in Chinese Participants With Overweight or Obesity

NCT07243171
recruitingphase_3

A Study of Econoglutide Injection in Obese Participants With Knee Osteoarthritis (KOA)

NCT07734311
View all 10 trials

Clinical Trials (10)

Showing 10 of 10 trials
NCT07553299Phase 2

A Study of Weekly Oral Dose of Ecnoglutide (VRB-101) for Weight Maintenance in Participants Who Have Obesity or Overweight With Weight-Related Comorbidities

Terminated
NCT07628127Phase 1

A Trial of Oral VRB-103 Alone or in Combination With Oral Ecnoglutide (VRB-101) in Participants With Obesity or Overweight

Recruiting
NCT07836270Phase 3

A Study of Ecnoglutide Injection in Overweight or Obese Chinese Adolescents

Not Yet Recruiting
NCT07243171Phase 1/2

A Phase Ib/IIa Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Oral Ecnoglutide Tablets in Chinese Participants With Overweight or Obesity

Recruiting
NCT07734311Phase 3

A Study of Econoglutide Injection in Obese Participants With Knee Osteoarthritis (KOA)

Recruiting
NCT07387094Phase 3

A Study of XW003 in Obese Participants With Obstructive Sleep Apnea But Not Receive Positive Airway Pressure Therapy

Recruiting
NCT07281937Phase 2

A Study of Weekly Oral Ecnoglutide (VRB-101) in Participants Who Have Obesity or Overweight With Weight-Related Comorbidities

Completed
NCT07073417Phase 2

A Study to Compare XW003 Injection and Semaglutide Injection in Chinese Adults With Obesity (SLIMMER-UP-SWITCH)

Active Not Recruiting
NCT05680155Phase 3

A Phase 3 Study to Evaluate the Efficacy of XW003 Compared With Placebo in T2DM Patients

Completed
NCT06335134Phase 1

A Drug-Drug Interaction Study Between XW003 and Metformin, Warfarin, Rosuvastatin or Digoxin

Completed

All 10 trials loaded

Drug Details

Intervention Type
Drug
Molecule Type
Protein
Total Trials
10

External References

ChEMBL
CHEMBL5095115

Names & Codes

Research Codes

XW-003